Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis
Michele Bartoletti, Marcella Montico, Domenica Lorusso, Roberta Mazzeo, Ana Oaknin, Lucia Musacchio, Giovanni Scambia, Fabio Puglisi, Sandro Pignata
Topics & Concepts
MedicineEndometrial cancerOncologyChemotherapyInternal medicineMeta-analysisPD-L1CancerImmunotherapyEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersSarcoma Diagnosis and Treatment